Latest Insider Transactions at Arca Biopharma, Inc. (ABIO)
This section provides a real-time view of insider transactions for Arca Biopharma, Inc. (ABIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARCA biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARCA biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2022
|
Funicular Fund, LP |
BUY
Open market or private purchase
|
Direct |
49,728
+2.43%
|
$99,456
$2.3 P/Share
|
|
Apr 04
2022
|
Funicular Fund, LP |
BUY
Open market or private purchase
|
Direct |
122,342
+5.92%
|
$244,684
$2.26 P/Share
|
|
Nov 22
2021
|
Christopher David Ozeroff S.V.P., General Counsel |
BUY
Open market or private purchase
|
Direct |
50,000
+49.52%
|
$100,000
$2.26 P/Share
|
|
May 12
2021
|
Robert E Conway Director |
BUY
Open market or private purchase
|
Direct |
10,000
+16.67%
|
$30,000
$3.19 P/Share
|
|
May 05
2021
|
Robert E Conway Director |
BUY
Open market or private purchase
|
Direct |
10,000
+20.0%
|
$30,000
$3.23 P/Share
|
|
Dec 18
2020
|
Robert E Conway Director |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$40,000
$4.16 P/Share
|